v3.25.1
EARNINGS (LOSS) PER SHARE
12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE

NOTE 6 – EARNINGS (LOSS) PER SHARE

 

The following table sets forth the computation of basic and diluted net loss per share of common stock for the years ended December 31, 2024 and 2023, respectively: 

        
   For the Year Ended December 31, 
   2024   2023 
Net loss attributable to common stockholders (basic)  $(764,655)  $(1,136,460)
Shares used to compute net loss per common share, basic and diluted   545,780,320    406,685,267 
Net loss per share attributable to common stockholders, basic and diluted  $(0.00)  $(0.00)

  

Basic net loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company’s potentially dilutive securities which include stock options, convertible debt, convertible preferred stock and common stock warrants have been excluded from the computation of diluted net loss per share as they would be anti-dilutive. For all periods presented, there is no difference in the number of shares used to compute basic and diluted shares outstanding due to the Company’s net loss position.

 

The following outstanding common stock equivalents have been excluded from diluted net loss per common share for the years ended December 31, 2024 and 2023, respectively, because their inclusion would be anti-dilutive:

        
   As of December 31, 
   2024   2023 
Warrants to purchase common stock       2,868,397 
Potentially issuable shares related to convertible notes payable and convertible preferred stock   764,494,742    837,994,510 
Potentially issuable vested shares to directors and officers   8,300,000     
Potentially issuable unvested shares to directors and officers   6,000,000     
Total anti-dilutive common stock equivalents   778,794,742    840,862,907